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Introduction: The kidneys are the dose-limiting organs in some radionuclide therapy regimens. However, the
biological impact of internal exposure from radionuclides is still not fully understood. The aim of this study
was to examine the effects of dose rate and time after i.v. injection of 177LuCl3 on changes in transcriptional
patterns in mouse kidney tissue.
Methods: To investigate the effect of dose rate, female Balb/c nude mice were i.v. injected with 11, 5.6, 1.6, 0.8,
0.30, and 0 MBq of 177LuCl3, and killed at 3, 6, 24, 48, 168, and 24 hours after injection, respectively.
Furthermore, the effect of time after onset of exposure was analysed using mice injected with 0.26, 2.4, and
8.2 MBq of 177LuCl3, and killed at 45, 90, and 140 days after injection. Global transcription patterns of
irradiated kidney cortex and medulla were assessed and enriched biological processes were determined from
the regulated gene sets using Gene Ontology terms.
Results: The average dose rates investigated were 1.6, 0.84, 0.23, 0.11 and 0.028 mGy/min, with an absorbed
dose of 0.3 Gy. At 45, 90 and 140 days, the absorbed doses were estimated to 0.3, 3, and 10 Gy. In general, the
number of differentially regulated transcripts increased with time after injection, and decreased with
absorbed dose for both kidney cortex and medulla. Differentially regulated transcripts were predominantly
involved in metabolic and stress response-related processes dependent on dose rate, as well as transcripts
associated with metabolic and cellular integrity at later time points.
Conclusion: The observed transcriptional response in kidney tissue was diverse due to difference in absorbed
dose, dose rate and time after exposure. Nevertheless, several transcripts were signiﬁcantly regulated in all
groups despite differences in exposure parameters, which may indicate potential biomarkers for exposure of
kidney tissue.
© 2014 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
In radionuclide therapy, normal tissue is a major limitation for the
amount of activity which can safely be administered to a patient.
Conventionally, bone marrow is regarded as the limiting organ with a
tolerance dose of 2.5 Gy (TD5/5) deﬁned for fractionated (2 Gy)
external radiation exposure [1]. In therapies using radiolabeled
peptides the kidneys are also, beside the bone marrow, a dose
limiting organ, where renal excretion, reabsorption, and retention of
the radionuclide occur [2,3]. According to external radiation therapy
the renal tolerance dose is 23 Gy (TD5/5) [4]. However, studies on, Sahlgrenska Academy at the
spital, SE-413 45 Göteborg,
Y-NC-ND license.patients and animals indicate a possibly higher tolerance dose value
for radionuclide therapy compared to external irradiation [5,6].
An important factor that must be considered in radionuclide
therapy is the dose rate [7,8]. The dose rate will depend on e.g. the
biokinetics and biodistribution of the radionuclide within the organ
and on the biological half-life of the radionuclide. The relation
between biological response and different dose rate is complex, and
will include dependencies on several physiological parameters, which
should be considered in the evaluation of the efﬁcacy of radionuclide
therapy [9].
It is clear that responses to irradiation within a speciﬁc organ are
polygenic and complex because of the collective effect of heterogeneous
cell content. Fromahistological point of view, different organs consist of
numerous specialized cell types where each tissue is subjected to its
own unique set of complex gene expression. Nevertheless, themajority
of studies showing transcriptional response after irradiation have been
performed in vitro using homogeneous cell populations. It is, therefore,
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in vivo observations of speciﬁc organs in an entire organism. Therefore,
studies on animals will further increase our knowledge of the effects of
radiation exposurewithin an organism. Recently, we investigated dose-
speciﬁc transcriptional variations in mouse kidneys 24 h after injection
of 177Lu-octreotate using genome-wide gene expression microarray,
where we identiﬁed speciﬁc biological and dose-dependent responses
in both kidney cortex andmedullawith strong associationwith immune
response at all of the investigated absorbed doses [10]. In addition, after
211At administration (0.24–160 mGy), a more pronounced transcrip-
tional response was observed at lower compared with higher absorbed
doses. Furthermore, changes in transcription have been previously
studied in mice after external irradiation of the kidneys using gene
expression microarray [11–13]. Despite varying results, these studies
indicate that acute-response processes and cell cycle regulation are
regulated shortly after irradiation (8–24 h), while apoptosis and
proliferation are detected at later time points (up to 30 weeks) after
10–16 Gy [11,13]. However, few studies have investigated the impact of
different dose rates on transcriptional variation in normal tissues after
internal radionuclide administration.
The aim of this study was to investigate dose rate- and time-
dependent effects on transcriptional variation in mouse kidney tissue
after injection of 177LuCl3. As described above, we have previously
investigated dose-speciﬁc transcriptional variations in mouse
kidneys 24 h after injection of 177Lu-octreotate, a radiopharmaceutical
used in treatment of somatostatin receptor overexpressing neuroen-
docrine tumors [10]. In the present study we chose to investigate the
effect of 177LuCl3 to study only the effect of ionizing radiation and avoid
potential biological effects of the hormone analogue octreotate.
2. Materials and methods
2.1. Radionuclide
177LuCl3 was acquired from I.D.B. Holland (I.D.B. Holland BV,
Baarle-Nassau, the Netherlands) and diluted with saline solution to
acquire the desired activity concentrations. The activities in the
syringes were measured before and after administration with a well-
type ionization chamber (CRC-15R; Capintec) to determine the
injected activities.
2.2. Animal handling and injection protocol
Adult female Balb/c nude mice were obtained from Charles River
(Charles River, Salzfeld, Germany) and divided into groups of three
animals each. The animals had free access to chow and water. The
experimental protocol was approved by the Ethics Committee for
Animal Studies in Gothenburg, Sweden.
2.2.1. Dose rate study
Five groups of animals were i.v. injected with 11, 5.6, 1.6, 0.80, and
0.30 MBq of 177LuCl3 and killed at 3, 6, 24, 48, and 168 h after
injection, respectively. The control group was i.v. injected with saline
solution and killed 24 h after injection. One kidney from each animal
was subjected to expression microarray analysis, whereas the
remaining kidney was used for activity concentration measurements
at the time of death.
2.2.2. Time study
Nine groups of animals were injected with 0.26, 2.4, or 8.2 MBq,
three groupswith each activity amount. Three control groups were i.v.
injectedwith saline solution. At 45, 90, and 140 days, one group of test
and one group of control animals were killed at each point-in-time
and the kidneyswere excised. One kidney per animalwas subjected to
expression microarray analysis, while the remaining kidney was ﬁxed
in formalin. The formalin ﬁxed kidneys were processed by standardtechniques for embedding in parafﬁn and sections (2 μm) were
stained with haematoxylin-eosin.2.3. Determination of activity concentration and mean absorbed dose
To determine the 177Lu activity in the kidneys, one kidney from
each animal in the dose-rate study was measured in a gamma counter
(Wallac 1480 Wizard® 3″: Wallac Oy, Turku, Finland). Estimations of
the absorbed dose to the kidneys were made according to the Medical
Internal Radiation Dose (MIRD) formalism [14]:
Dkidney ¼ eAkidney 
X
niEi Φi=mkidney;
where Ãkidney is the cumulated activity in the kidneys, the product niEi
is the average energy per decay (147 keV), ϕi is the absorbed fraction,
and mkidney is the mass of the kidney. The value of the absorbed
fraction (ϕi = 0.93) was taken from literature [15]. To determine the
cumulated activity, a monoexponential curve was ﬁtted to the
measured activity concentrations of the kidney, and the integral
was calculated for the different time points. For the dosimetric
calculations, the activity distribution in the kidneys was considered
homogeneous. Only the contribution from electrons was included.2.4. Gene expression analysis and data processing
Total RNA for microarray experiments was extracted from kidney
cortex and kidney medulla, respectively, using the RNeasy Lipid Tissue
Mini Kit (Qiagen, Hilden, Germany). RNA quality assessment was
performed using Agilent 2100 Bioanalyzer, as previously described
[10,16]. Transcripts with adjusted p-values b0.01 (Bonferroni multiple
testing) and log2-ratio N0.58 or log2-ratio b−0.58 were considered
signiﬁcant. OverrepresentedGeneOntology terms (p-valueb0.05)were
identiﬁed using Nexus Expression 3.0. Generated gene expression
proﬁles are available from the NCBI's Gene Expression Omnibus (GEO
accession number GSE53164).2.5. Western blot
Western blot was carried out to analyze the protein expression
levels of Havcr1 and Lcn2. Kidney cortex and medulla tissue samples
were homogenized in Mammalian Cell Lysis Buffer including
Benzonase® Nuclease and Protease Inhibitor Solution using the
Mikro-Dismembrator S ball mill (Sartorius Stedim Biotech, Aubagne
Cedex, France). Cell debris was removed by centrifugation and the
protein extract was stored at -20 °C. Protein extracts (100 μg) were
run on SDS-PAGE using 4–12% Bis-Tris gels (Invitrogen, Carlsbad, CA,
USA) and transferred to nitrocellulose membranes. The anti-Tim-1
primary antibody (MAB 1817, R&D systems, Minneapolis, MN, USA)
speciﬁc to Havcr1 protein was detected by a secondary Rat IgG
Horseradish Peroxidase-conjugated antibody (HAF005, R&D systems,
Minneapolis, MN, USA). The antibodies were stripped from the
membranes in a stripping buffer and reprobed by the anti-Lcn2 (PAB
9542, Abnova, Taipei city, Taiwan) speciﬁc to Lcn2 protein and
detected by Rabbit IgG Horseradish Peroxidase-conjugated antibody
(NA934V, Amersham, Piscataway, USA). beta-Actin was used as an
experimental internal control and therefore was detected by probing
on stripped ﬁlter with the anti-ACTB and Mouse IgG Horseradish
Peroxidase-conjugated antibody (NA931V, Amersham, Piscataway,
USA). SuperSignal® West Femto Maximum Sensitivity Substrate
(Thermo Scientiﬁc, Waltham, MA, USA) was used for detection and
digitalized images were acquired using Fujiﬁlm Luminescent Image
Analyzer LAS-1000 (Fujiﬁlm, Tokyo, Japan).
Fig. 1. Total number of up- (positive numbers) and down-regulated (negative numbers) transcripts in kidney cortex andmedulla after exposure to different dose rates from 177LuCl3
(total absorbed dose of 0.3 Gy). The mice were killed 3, 6, 24, 48, and 168 h after injection.
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The mean absorbed dose delivered to the kidneys in animals killed
at 3, 6, 24, 48 and 168 h was 0.30 ± 0.01 Gy (mean ± SEM) with
average dose rates of 1.6, 0.84, 0.23, 0.11 and 0.028 mGy/min,
respectively. The number of differentially regulated transcripts in
kidney cortex ranged from 22 to 135 and in kidneymedulla from 38 to
159 following exposure to different dose rates (Fig. 1). The lowest
number of differentially regulated transcripts in the kidney cortexwas
found at 0.11 mGy/min (22 transcripts), with a relatively similar
response in number of regulated transcripts at the other dose rates
(range: 99-135 transcripts). The lowest number of differentially
regulated transcripts in kidney medulla was detected at 0.028 and
0.11 mGy/min (38-41 transcripts), and the highest at 0.84 mGy/min
(159 transcripts) (Fig. 1).
Few transcripts were recurrently regulated between the dose rate
groups and the Serpina10 genewas unique in being regulated in all dose
rate groups for both tissues (Fig. 2). The Havcr1 and Ly6f genes were
regulated in cortex, while the Ccl8, Lcn2, and Cml3 geneswere regulated
inmedulla at all dose rates. Additionally, theHavcr1 genewas regulated
in kidney medulla at 0.23 and 0.84 mGy/min, and the Lcn2 gene was
regulated in kidney cortex at 0.11–0.84 mGy/min. Variation in Havcr1
gene expression was further validated by Western blot.
Differentially regulated transcripts were divided into eight main
categories, and corresponding subcategories, by biological function
(DNA integrity, gene expression integrity, cellular integrity, cell cycle
and differentiation, cell communication, metabolism, stress response,
and organismic regulation) (Table 1). Transcription, a sub category ofFig. 2. Gene expression patterns for a selection of genes regulated in kidney cortex and med
*Signiﬁcant regulation (see Materials and Methods).gene expression integrity, had the highest proportion (11.5%) of
transcripts regulated after 0.84 mGy/min in kidney cortex (Table 1).
At the remaining investigated dose rates, transcriptionwas represented
by less than 6.8 % of the regulated transcripts. No transcription-
associated transcripts were detected at 0.11 mGy/min. In kidney
medulla, transcription was represented to a higher extent compared
with cortex and involved 7.9–14% of the regulated transcripts, where
the highest proportion was detected at 0.23 mGy/min. Regulated
transcripts involved in cellular integrity and speciﬁcally in supramo-
lecular maintenance were highly represented (2.0–15%), with the
highest response at 0.23 mGy/min in kidney cortex (15%). Transcripts
involved in cell communication (signal transduction) were frequently
regulated (2.4–8.1%) in kidney medulla, whereas transcripts associated
with metabolism were commonly regulated in kidney cortex, in
particular transcripts associated with protein and amino acid metabo-
lism (7.4–23% with the highest value observed at 0.11 mGy/min). The
highest number of regulated transcripts was in general associated
with immune response in both tissues (9.0-39%). Regulation of immune
response was most prominent in the lowest dose rate group with
25% and 39% of the differentially regulated transcripts detected in
kidney cortex and medulla, respectively. Many transcripts (25% and
23%) associated with immune response were also regulated at
0.84 mGy/min.
After 45, 90 and 140 days, the mean absorbed doses following the
injected activities of 0.26, 2.4, and 8.2 MBq were estimated to 0.3, 3,
and 10 Gy, respectively, irrespective of time-point. The number of
regulated transcripts in the kidney cortex was zero at 45 days, and
then increased with time after injection for all absorbed dose levelsulla after exposure to different dose rates from 177LuCl3. Values are given as log2 ratios.
Table 1
Differentially regulated transcripts. Differentially regulated transcripts in kidney cortex and medulla categorized according to higher level biological function. For the main category
(given in bold) the number of differentially regulated transcripts per category is shown. The subcategories for each main category are also shown, with the percentage of transcripts
regulated compared to the total number of regulated transcripts for a particular dose rate. The percentage of scored transcripts is colour coded according to strength of regulation.
Dose rate (mGy/min) Kidney cortex Kidney medulla
0.028 0.11 0.23 0.84 1.6 0.028 0.11 0.23 0.84 1.6
DNA integrity 0 0 0 0 1 0 0 0 0 2
Chromatin organization - - - - 0.9% - - - - 1.8%
Damage and repair - - - - - - - - - -
Gene expression integrity 4 0 4 15 8 5 3 15 21 16
RNA-processing - - - - - - - - - 0.9%
Transcription 4.0% - 3.0% 11.5% 6.8% 12.2% 7.9% 14.1% 11.9% 13.5%
Translation - - - 0.8% - - - 1.0% 1.3% -
General - - - - - - - - - -
Cellular integrity 14 5 35 14 18 4 9 12 18 20
Cytoskeleton and motility 1.0% 4.5% 2.2% 1.6% 1.7% - 5.3% 2.0% 0.6% 1.8%
Extracellular matrix and cellular membrane 2.0% 4.5% 0.7% 4.1% 0.9% 2.4% 7.9% 4.0% 4.4% 2.7%
Physico-chemical environment 3.0% - 5.9% 2.5% 4.3% - - 4.0% 1.3% 2.7%
Supramolecular maintenance 5.1% 9.1% 14.8% 2.5% 8.5% 7.3% 7.9% 2.0% 3.1% 7.2%
General 3.0% 4.5% 2.2% 0.8% - - 2.6% - 1.9% 3.6%
Cell cycle and differentiation 3 1 10 9 8 2 5 10 15 12
Apoptotic cell death 1.0% 4.5% 3.7% 2.5% 4.3% 2.4% 7.9% 2.0% 2.5% 3.6%
Cell cycle regulation - - 1.5% 3.3% - - 2.6% 4.0% 4.4% 3.6%
Cell death - - - - - - - 1.0% - 0.9%
Differentiation and aging 2.0% - 2.2% 1.6% 2.6% 2.4% 2.6% 3.0% 2.5% 2.7%
General - - - - - - - - - -
Cell communication 3 0 3 4 4 1 3 8 8 6
Intercellular signaling - - - - - - - - - -
Signal transduction 3.0% - 2.2% 3.3% 3.4% 2.4% 7.9% 8.1% 5.0% 5.4%
Metabolism 35 9 46 34 43 5 6 22 40 26
Carbohydrates 1.0% - 4.4% 3.3% 2.6% 2.4% 2.6% 3.0% 2.5% 3.6%
Lipids, fatty acids 6.1% - 5.9% 4.1% 6.8% 7.3% - 6.1% 5.7% 4.5%
Proteins, amino acids 16.2% 22.7% 11.9% 7.4% 12.8% 2.4% 2.6% 4.0% 6.9% 4.5%
Signaling molecules 1.0% - - 0.8% 0.9% - - - 0.6% -
Nucleic acid related 1.0% - - 1.6% 0.9% - - - 1.3% 0.9%
General 6.1% 4.5% 8.1% 8.2% 8.5% - 7.9% 7.1% 6.9% 7.2%
Other 4.0% 13.6% 3.7% 2.5% 4.3% - 2.6% 2.0% 1.3% 2.7%
Stress responses 25 3 18 35 23 18 7 20 43 13
Oxidative stress response - - - - - - 2.6% 1.0% 0.6% 0.9%
Inﬂammatory response - - 3.0% 1.6% 0.9% 2.4% 2.6% 2.0% 1.3% -
Immune response 25.3% 13.6% 9.6% 24.6% 17.9% 39.0% 10.5% 15.2% 22.6% 9.0%
General - - - 0.8% - 2.4% 2.6% 1.0% 0.6% -
Other - - 0.7% 1.6% 0.9% - - 1.0% 1.9% 1.8%
Organismic regulation 4 2 3 3 3 2 2 2 6 1
Behavior - - - - - - - - - -
Ontogenesis - 4.5% 1.5% - 0.9% - - - - -
Systemic regulation 4.0% 4.5% 0.7% 2.5% 1.7% 4.9% 5.3% 2.0% 3.8% 0.9%
Reproduction - - - - - - - - - -
Unknown function 11 2 16 8 9 4 3 10 8 15
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by a factor of 2.5 compared with that at 90 days for the groups
receiving 10 Gy, while a 3-fold increase was observed for the groups
exposed to 0.3 and 3 Gy. The number of regulated transcripts were
lower at 10 Gy compared with that for the other absorbed doses. In
kidney medulla the number of differentially regulated transcripts also
varied with absorbed dose and time (Fig. 3B). No differentially
regulated transcripts were detected at 45 days after 10 Gy. The
number of regulated transcripts increased with time after 0.3 and
10 Gy, whereas the highest number of regulated transcripts (n = 55)
was found at 90 days after 3 Gy.
Several genes were recurrently detected at different absorbed
doses and time points such as Slc22a9 andNapsa, which are associated
with cellular integrity andmetabolism, respectively. Other genes from
the Slc-family were also frequently detected, primarily in kidney
cortex. The Igf2 gene, involved in cell cycle and differentiation, and the
Pck1 and Car3 genes, involved in metabolism, were frequently
regulated in both tissues.
In general, transcripts associated with metabolism were most
prevalent in both tissues. However, none of the transcripts detected
after exposure to 10 Gy were associated with metabolism in kidney
medulla, independent of time after injection. The categorization ofdifferentially regulated transcripts showed an association with gene
expression integrity, mainly at 90 and 140 d (Fig. 4, Supplementary
Tables 1 and 2). Furthermore, a high number of differentially regulated
transcripts were associated with cellular integrity, cell cycle regulation
and differentiation, with more prominent regulation in kidney cortex
thanmedulla. Transcripts involved in DNA integrity were only detected
after 140 d at 0.3 Gy in kidney medulla. (See Fig. 5.)
The histological evaluation revealed no or onlyminormorphological
changes in the exposed kidneys compared to kidneys from controlmice.
4. Discussion
In the present study, transcriptional variations induced by internal
exposure from 177LuCl3 were investigated in mouse. We used a
comprehensive approach to investigate the effects of dose rate, time
after injection, and absorbed dose after radionuclide injection on
transcriptional regulation. It is unfortunately not possible to study
pure effects due to differences in dose rate, since the absorbed dose
and/or the time after injection will inevitably be altered. Differentially
regulated transcripts and enriched biological processes were identi-
ﬁed and categorized according to higher level cellular function.
Diverse response patterns were seen with substantial differences in
Fig. 3. Total number of signiﬁcantly up- and down-regulated transcripts 45, 90, and 140 days after 0.3, 3, and 10 Gy exposure from 177LuCl3 in kidney cortex (A) and medulla
(B), respectively. Positive numbers refer to up-regulation, while negative numbers refer to down-regulation.
829E. Schüler et al. / Nuclear Medicine and Biology 41 (2014) 825–832the number of regulated transcripts between the groups, as well as
their associated biological functions.
The biodistribution following 177LuCl3 administration has previously
been investigated in human small cell lung cancer xenografted Balb/c
mice [17], where the activity concentration in the kidneys was 3.7%IA/g
and 1.8%IA/g 24 and 168 h after injection, respectively. This is not in
agreement with the present results, where the activity concentrations
for the time-points of 24 and 168 h after injection were 14%IA/g and
5.3%IA/g, respectively. This discrepancymay beexplainedbydifferences
in age and potential physiological effects of tumour tissue. However,
only minor differences in the activity concentration in the lungs, liver,
spleen, and pancreas were obtained between the studies. Therefore, the
activity concentration values measured in the present study were used
for the absorbed dose calculations.
In the present study, the histological evaluation revealed no dilatation
of the proximal or distal tubules after exposure, and no effects were
observed on the glomeruli. To our knowledge, histological changes of
the kidneys have not previously been investigated after 177LuCl3
administration. However, after 177Lu-octreotate administration, dose-
dependentmorphological changes have been observed. In rats exposed to
92 Gy after 177Lu-octreotate administration, pronounced changes (e.g.
inhomogeneous nuclei, apoptotic and necrotic cells) in proximal and
distal tubules was observed after 109 days, and similar results but to a
lesser extent was seen after 46 Gy [18]. A previous study on Balb/c mice
revealed ﬂattened epithelium, loss of brush border, dilatation, and empty
lumina in the proximal tubules after 177Lu-octreotate administration
(absorbed dose to kidneys of 35–58 Gy, 6 months after injection) [6].
Furthermore,nooronlyverymild changeswereobserved in theglomeruli
in both studies. Thedifference in results comparedwith that of thepresent
study can be explained by the lower absorbed dose delivered to the
kidneys in our study (0.3–10 Gy), maybe together with possibly different(spatial and temporal) exposure conditions between free and bound
177Lu.
In kidney cortex, no differentially regulated transcripts were
detected at 45 d after injection at any absorbed dose investigated. In
addition, few differentially regulated transcripts were detected in
kidney medulla at 45 d, with 5, 6, and 0 regulated transcripts at the
absorbed doses of 0.3, 3, and 10 Gy, respectively. The number of
differentially regulated transcripts generally increased with time
(45–140 d) for all absorbed doses for both tissues, and was most
prominent in the 0.3 and 3.0 Gy groups in kidney cortex. The only
exception was at 90 d after 3 Gy in kidney medulla. The increase in
the regulation of genes at later time points may partly be explained
by an alteration in the microenvironment, affecting cell phenotype,
tissue composition, and the physical interaction and signalling
between cells [19]. Previous studies have shown that in access of
DNA damage response, the response at the tissue level from
activation of cytokines, growth factors and chemokines can induce
persistent remodelling of the extracellular matrix, affecting the
overall response of the tissue [19].
Overall, the number of regulated transcripts was lower at 10 Gy
than at 0.3 and 3 Gy. Furthermore, the decrease of differentially
regulated transcripts with absorbed dose indicates that the cellular
response was less diversiﬁed at increased absorbed dose. This has
previously been observed in the thyroid after injection of different
amounts of the radionuclide 211At [20,21]. It was hypothesized that at
high absorbed doses, the DNA lesionswere too complex to be properly
repaired, resulting in reduced cellular response compared to the
lower absorbed doses.
The transcriptional responsewas to a large extent uniquely regulated
at a speciﬁc dose rate, time point, and/or absorbed dose. Few
differentially regulated transcripts were observed at 0.028 mGy/min
Fig. 4. Number of differentially regulated transcripts in (A) kidney cortex and (B) kidney medulla 45, 90, and 140 days after injection for the absorbed doses of 0.3, 3, and 10 Gy.
Regulated transcripts are categorized according to higher level biological function.
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2-fold was observed at dose rates higher than 0.11 mGy/min. The
transcriptional response observed at 0.028 mGy/min in kidney cortex
was higher compared with medulla (99 vs. 41 differentially regulated
transcripts, respectively), while the response of the two tissues was
relatively similar at all other dose rates investigated. Due to the relatively
long range of electrons emitted by 177Lu and the close proximity of the
two tissues, the irradiation parameters can be assumed to be similar andFig. 5. Histological slices of the kidney cortex. The slices are stained with haematoxylin-eosin
control animal and (B) shows the morphology 140 days after 177LuCl3 administration (10 Gsimilar biological response could be expected. Although several
transcripts were regulated at all dose rates, only the Serpina10 gene
wasdifferential regulated at all dose rates in both tissues, indicating some
similarity in the regulation of proteolysis and coagulation. Speciﬁcally,
the Havcr1 and Ly6f genes were regulated at all dose rates in kidney
cortex, whereas the Lcn2, Clm3, and LOC100048554 (Ccl8) genes were
regulated at all dose rates in kidneymedulla. Several of these genes have
previously been proposed as biomarkers for acute kidney injury [22]. Theand the images are shown with 10× magniﬁcation. (A) shows the morphology from a
y).
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(kidney injury molecule 1), has been used in preclinical studies as a
predictorof kidney tubular damage inavarietyof animals, and inhumans
[23,24]. Previous studies have shown that Kim-1mRNA level is elevated
after tubular damage and its corresponding protein is detected in the
urine where it is considered as a promising marker for early kidney
damage [23,24]. In the present study Kim-1 gene was down-regulated in
kidney cortex at all dose rates and at 0.23 and 0.84 mGy/min in kidney
medulla, both at the transcriptional and protein level, which is in
contradiction with previous results where the Kim-1 gene was up-
regulated after chemically induced tubular damage [23–25]. The Lcn2
(lipocalin 2), also known as NGAL (neutrophil gelatinase-associated
lipocalin), was down-regulated after 177LuCl3 administration for all dose
rate groups in kidney medulla. Signiﬁcant down-regulation was also
found for the 0.11–0.84 mGy/min dose rates in kidney cortex. However,
the protein expression could not be determined due to technical
difﬁculties. Other studies showed that the NGAL gene was up-regulated
within a few hours of harmful injury and was among the earliest genes
induced after injury, where theNGAL proteinwas detected in both blood
andurine [26,27]. Therefore, this genemay also be considered as a potent
novel biomarker for early kidney tubule injury. The Cxcl1, Cd14 and Egr1
geneshavepreviously also beenassociatedwith kidney injury [28]. In the
present study, the Cxcl1 and Cd14 geneswere down-regulated at all dose
rates except for the highest dose rate in kidney medulla. The Egr1 gene
was down-regulated at 0.11, 0.23, and 1.6 mGy/min and after 0.3 and
3 Gy at 140 d in kidney medulla. While these types of studies are
paramount in the search for genetic markers of radiation insult, more
data are needed before any clear conclusions can be drawn. This study
show several potentially interesting markers, but the correlation
between early indicators and late toxicity needs to be established in
order to evaluate their potential role as clinically useful biomarkers of
radiation insult. Further research including other radionuclides and
larger intervals of dose rates, absorbed doses, and time after injection
needs to be undertaken, as well as measurements of protein levels in
blood, urine, and speciﬁc cell types in kidney tissue using immunohis-
tochemistry to validate the role of these genes as biomarkers for radiation
exposure of kidney.
The effects of DNA damage after irradiation include the activation of
cellular defence mechanisms, such as DNA repair and inﬂammatory
response, which should be prioritized in affected tissues and cells after
irradiation [29]. However, it has also been suggested that low dose rate
exposure results in down-regulation of ATM (ataxia-telangiectasia
mutated), a kinase involved in the detection of DNA damage and
initiation of cell cycle arrest, whichmay in turn down-regulate the early
DNA damage response of exposed cells [30,31]. In the present study,
transcripts associatedwithDNAdamage and repairwasnot signiﬁcantly
affected. Instead, regulated transcripts associated to metabolism,
cellular integrity and stress responseweremost prevalent. These results
are in agreementwithpreviously published in vitro studies ongenotoxic
stress, where diverse responses were observed with modulation of
e.g. cell cycle regulation, metabolism, communication, and RNA
processing [32–34], suggesting that despite the lack of DNA damage
and repair associated transcripts, the response observed is partly a result
of the direct DNA damaging properties of radiation.
A few studies on dose rate effects on gene expression have been
published. Previously, the ML-1 cell line (human myeloid leukemia
cell line) was used to analyse the dose rate effects on gene expression
regulation after 2.8 and 2,900 mGy/min up to 20–500 mGy of external
irradiation [35]. Dose rate speciﬁc effects were observed for the
GADD45A and CDKN1A genes (increased expression with dose rate)
following exposure. Furthermore, a clear dose rate effect on apoptosis
was observed, whereas no difference in cell cycle regulation was seen.
None of the proposed radiation-associated genes in that study were
differentially regulated in the present study [35]. In addition, we did
not ﬁnd any dose rate effect on apoptosis or cell cycle-associated
genes. However, there are many discrepancies between the studyprotocols of the two studies, e.g. tumour cell line in vitro versus normal
tissue in an organism, external versus internal irradiation. Further-
more, the effect seen in the present study is a combination between
dose rate and time after injection, due to the fact that the mice were
killed at different time points after injection, in order to keep the
absorbed dose constant between the groups. In addition, the dose rate
depend on the time after injection, with the highest dose rate taking
place shortly after injection.
A consequence of radionuclide administration is that all organs and
tissues in the body are exposed to various amounts of ionizing radiation
emitted by the radionuclidewith resultingwhole body systemic effects,
which complicates the analysis of speciﬁc organs. Therefore, the
detected responses in kidney tissue may be understood as not only a
single consequence of kidney irradiation, but also an effect of crosstalk
between different tissues and organs. Thus, systemic effects should be
considered when evaluating the biological response [21]. Previous
studies using transcriptional variation to identify novel biomarkers for
absorbed dose to the kidneys after irradiation with 131I (0.17–3.5 mGy
after 24 h) and 211At (0.24–160 mGy after 24 h) have been performed
[16,21]. However, none of the identiﬁed transcripts in those studies
revealed monotonic changes in expression levels with absorbed dose
suitable to be considered as novel radiation-induced biomarkers.
Nevertheless, Angptl4 gene expression levels were differentially
regulated at all absorbed doses after administration of 211At for kidney
cortex and medulla, lungs, and spleen [21]. In the present study, this
genewas also differentially regulated between 0.23 and 1.6 mGy/min in
both tissues. In addition, the Slpi gene was differentially regulated at all
absorbed doses for kidneymedulla following 211At irradiation but in the
present study it was only detected at 1.6 mGy/min (the highest dose
rate). Furthermore, in a study on mice exposed to a single acute
absorbed dose of 16 Gy using 250 kV X-rays 40, 46, and 206
differentially regulated genes were identiﬁed in the kidneys after 10,
20, and 30 weeks, respectively [11]. This can be compared with the
number of differentially regulated transcripts (0, 10, and 25 transcripts
in kidney cortex and 0, 3, and 5 transcripts in kidney medulla) found in
the present study 45, 90, and 140 days after injection of 177Lu resulting
in 10 Gy to kidney.
Lately, the possibility of using alpha particle emitting radionu-
clides conjugated to somatostatin analogues has gained interest,
e.g. octreotate labeled with 211At, 212Bi, 213Bi and 225Ac, and
biomarkers predicting radiation insult needs to be explored for
these radiopharmaceuticals. The limited data so far show large
differences in gene expression response in normal tissues between
beta and alpha emitting radionuclides [10,16,21]. Furthermore, large
differences in response between 177Lu-octreotate and the present
study using 177LuCl3 are also evident, indicating the effect of
octreotate and differences in biodistribution and systemic effects.
No clear correlation between biological response and absorbed dose,
dose-rate, and time after injection have yet been established, partly
due to the different study protocols employed in the studies
presented so far. Further studies are clearly needed where the
dependencies of radiation quality as well as the presence of hormone
analogues are investigated further. Most probably, separate studies
of each radiopharmaceutical will be necessary.
5. Conclusion
Dose rate effects are most probably important issues in radionu-
clide therapy, where the kidneys sometimes are one of the dose
limiting organs. In the present investigation, transcriptional variation
increased with time after injection compared to control, but
decreased with absorbed dose. Metabolic and stress response-related
transcripts were most prevalent, in particular after exposure to
varying dose-rates, while cellular integrity-related processes were
time-dependent. Transcripts detected in multiple exposure groups
were also found, and should be tested as potential biomarkers for
832 E. Schüler et al. / Nuclear Medicine and Biology 41 (2014) 825–832exposure of kidney tissue. However, further research on biomarkers
for kidney injury and individual sensitivity needs to be done in order
to ﬁnd clinically useful biomarkers to develop personalized therapy,
and increase therapeutic success and patient well-being.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nucmedbio.2014.07.010.
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